Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
The Grey Market Problem A quick internet search for "BPC-157" returns dozens of websites selling peptides under the guise of "research use only." These vendors operate in a regulatory grey area, selling peptides technically labeled for research but clearly marketed toward human use
Zheng Y, Zhou C, Yu XX, Wu C, Jia HL, Gao XM, Yang JM, Wang CQ, Luo Q, Zhu Y, et al
The MHRA has licensed several GLP-1 agonists for use in the UK, and NICE guidelines (NG28) recommend them for specific patient groups, particularly those with type 2 diabetes who have not achieved adequate control with other medications or who have additional cardiovascular risk factors
The average of seven RCTs showed a decrease of 3.54 mg/dL (9 nmol/L).[ref] While a small reduction, it may be significant when combined with other interventions.[ref] Related article: CoQ10: background science, mitochondrial energy, and genetic variants Niacin: Vitamin B3 niacin has been used for decades to lower the risk of heart disease
Loss of neurons and increased edema in the anterior horn and gray matter was also observed in the control groups, however, all rats treated with BPC-157 were able to counteract the disturbances [3]
US$ 20.63
US$ 27.07
US$ 24.51
US$ 21.91
US$ 29.82
